← All organizations

ImCheck Therapeutics

For profitWebsite ↗

Also known as: ImCheck Therapeutics

Highest phase reached

Phase 2

First clinical trial

Jan 31, 2020

Last known activity

Apr 19, 2022

Acquired by Ipsen on Oct 22, 2025

Timeline

2010s

  1. Jan 1, 2015

    ImCheck Therapeutics— Founded

2020s

  1. Oct 22, 2025

    Ipsen— Acquired By

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Recent trials (5)

Details

Founded
Marseille, FR Jan 1, 2015
Last known activity
Apr 19, 2022